Lidocaine for systemic sclerosis: a double-blind randomized clinical trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lidocaine for systemic sclerosis: a double-blind randomized clinical trial

Published:2011 Issue:1 Volume:6 Page:5
ISSN:1750-1172
Container-title:Orphanet Journal of Rare Diseases
language:en
Short-container-title:Orphanet Journal of Rare Diseases

Author:

Riera Rachel,Andrade Luís EC,Souza Alexandre WS,Kayser Cristiane,Yanagita Edison T,Trevisani Virgínia FM

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Genetics(clinical),General Medicine

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of rituximab in the treatment of systemic sclerosis: A literature review;Modern Rheumatology;2023-04-13

2. Comparison of the efficacies of polycaprolactone filler and lidocaine‐added filler on neocollagenesis in a rat model;Journal of Cosmetic Dermatology;2021-12-11

3. Upcoming treatments for morphea;Immunity, Inflammation and Disease;2021-07-17

4. Inflammatory arthritis in systemic sclerosis: What to do?;Journal of Scleroderma and Related Disorders;2018-06-19

5. Musculoskeletal Involvement in Systemic Sclerosis: An Unexplored Aspect of the Disease;Journal of Scleroderma and Related Disorders;2016-12-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP